Retrospective Effectiveness Study of Dalbavancin and Other Standard of Care of the Same Class in Patients With ABSSSI

NCT04298463 · clinicaltrials.gov ↗

COMPLETED

Status

184

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Bacterial Skin and Skin Structure Infection

Interventions

DRUG: Xydalba
DRUG: vancomycin, teicoplanin or daptomycin

Sponsor

Aziende Chimiche Riunite Angelini Francesco S.p.A

Collaborators

[object Object]